Your session is about to expire
← Back to Search
Educational Video for Prostate Cancer
N/A
Waitlist Available
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Study Summary
This trial aims to improve rates of genetic testing in Black patients with aggressive prostate cancer to help inform treatment decisions. #GeneticTesting #ProstateCancer #BlackPatients #NCCN
Who is the study for?
This trial is for black or multiracial men including black, aged 18+, with high-risk prostate cancer. They should meet NCCN guidelines for germline testing and have a significant family history of certain cancers or a diagnosis of aggressive prostate cancer regardless of family history. Men who've already had genetic testing are excluded.Check my eligibility
What is being tested?
The study tests whether an educational video can increase the completion rates of recommended genetic testing in black patients with high-risk prostate cancer. Participants will watch an educational session and may then undergo genetic testing.See study design
What are the potential side effects?
Since this intervention involves only watching an educational video and potentially undergoing standard genetic testing, there are no direct physical side effects expected from participating in this clinical trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Testing rate
Secondary outcome measures
Baseline knowledge per "Patient Survey on Germline Testing in Prostate Cancer" questionnaire
Clinician attitudes per "Post Results Clinician Questionnaire"
Post-intervention knowledge per "Patient Post-Education Patient Survey" questionnaire
Trial Design
1Treatment groups
Experimental Treatment
Group I: Educational interventionExperimental Treatment1 Intervention
Patients will be asked questions about genetic testing for prostate cancer before and after an educational intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational video
2014
Completed Phase 3
~3610
Find a Location
Who is running the clinical trial?
Henry Ford Health SystemLead Sponsor
300 Previous Clinical Trials
2,099,949 Total Patients Enrolled
3 Trials studying Prostate Cancer
68 Patients Enrolled for Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a man with low to intermediate risk prostate cancer and have a significant family history of cancer.I have undergone genetic testing.I am a man aged 18 or older.My genetic test shows a possible inherited variant.I am a man with high-risk or very high-risk prostate cancer, including if it has spread to lymph nodes or is metastatic.I identify as black or multiracial including black.I qualify for genetic testing based on national cancer guidelines.I have been diagnosed with prostate cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Educational intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still open positions available in this clinical examination?
"As indicated by the clinicaltrials.gov database, this medical research is not accepting any more patients at this time - despite being first posted on October 1st 2023 and updated as recently as July 14th 2023. Nonetheless, there are still 1338 other trials open for enrollment right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger